SEARCH

SEARCH BY CITATION

References

  • 1
    Richter GM, Nöldge G, Palmaz JC, Rössle M, Slegerstetter V, Franke M, Gerok W, et al. Transjugular intrahepatic portocaval stent shunt: preliminary clinical results. Radiology 1990; 174:10271030. MEDLINE
  • 2
    Bosch J. TIPS: the first decade. In: ArroyoV, BoschJ, BrugueraM, RodésJ, Sánchez TapiasJM, eds. Treatment of Liver Diseases. Barcelona: Masson S.A, 1999: 312.
  • 3
    Rössle M, Haag K, Ochs A, Sellinger M, Nöldge G, Perarnau JM, Berger E, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330:165171. MEDLINE
  • 4
    Casado M, Bosch J, García-Pagán JC, Bru C, Bañares R, Bandi JC, Escorsell A, et al. Clinical events following TIPS: correlation with hemodynamic findings. Gastroenterology 1998; 114:12961303. MEDLINE
  • 5
    Cabrera J, Maynar M, Granados R, Gorriz E, Reyes R, Pulido-Duque JM, Rodríguez SanRoman JL, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996; 110:832839. MEDLINE
  • 6
    Sanyal AJ, Freedman AM, Luketic VA, Purdum PP III, Shiffman ML, Cole PE, Tisnado J, et al. Transjugular intrahepatic portosystemic shunt compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann Int Med 1997; 126:849857.
  • 7
    Cello JP, Ring EJ, Olcott EW, Koch J, Gordon R, Sandhu J, Morgan DR, et al. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Int Med 1997; 126:858865.
  • 8
    Merli M, Salerno F, Riggio O, De Franchis R, Fiaccadori F, Meddi P, Primignani M, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Hepatology 1998; 27:4045.
  • 9
    García-Villareal L, Martínez-Lagares F, Sierra A, Guevara C, Marrero JM, Jiménez E, Monescillo A, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. Hepatology 1999; 29:2732. MEDLINE
  • 10
    Jalan R, Forrest EH, Stanley AJ, Redhead DR, Forbes J, Dillon JF, MacGilchrist AJ, et al. A randomized trial comparing Transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology 1997; 26:11151122. MEDLINE
  • 11
    Rössle M, Deibert P, Haag K, Ochs A, Olschewski M, Siegerstetter V, Hauenstein KH, et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997; 249:10431049.
  • 12
    Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for rebleeding. Gastroenterology 1997; 113:16231631. MEDLINE
  • 13
    Groupe d'Etude des Anastomoses Intra-Hépatiques. TIPS vs sclerotherapy + propranolol in the prevention of variceal rebleeding: preliminary results of a multicenter randomized trial [Abstract]. Hepatology 1995; 22:A297.
  • 14
    Sauer P, Theilmann L, Benz C, Richter G, Stremmel W, Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus endoscopic banding in the prevention of variceal rebleeding: interim analysis of a randomized study [Abstract]. Gastroenterology 1997; 111:A1374.
  • 15
    Pomier-Layrargues G, Villeneuve JP, Deschenes M, Lambert J, Fenyves D, Willems B, Marleau D, et al. TIPS vs endoscopic variceal ligation in the prevention of variceal rebleeding in cirrhotic patients: a comparative randomized clinical trial (a final report) [Abstract]. Hepatology 1999; 30:A1036.
  • 16
    Luca A, D'Amico G, La Galla R, Midiri M, Morabito A, Pagliaro L. TIPS for prevention of variceal bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 1999; 212:411421. MEDLINE
  • 17
    Escorsell A, Garcia-Pagán JC. TIPS in the prevention of variceal rebleeding. Results of randomized controlled trials (RCT). In: ArroyoV, BoschJ, BrugueraM, RodésJ, Sánchez TapiasJM (eds). Treatment of Liver Disease. Barcelona: Masson, S.A., 1999: 2530.
  • 18
    Barton RE, Rösch J, Saxon RR, Lakin PC, Petersen BD, Keller FS. TIPS: short and long-term results: a survey of 1750 patients. Semin Intervent Radiol 1995; 12:364367.
  • 19
    Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis. Hepatology 1999; 30:612622. MEDLINE
  • 20
    Somberg KA, Riegler JL, LaBerge JM, Doherty-Simor MM, Bacchetti P, Roberts JP, Lake JR. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol 1995; 4:549555.
  • 21
    Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP III, Luketic VA, Cheatham AK. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994; 20:4655. MEDLINE
  • 22
    Riggio O, Merli M, Pedretti G, Servi R, Meddi P, Lionetti R, Rossi P, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors. Dig Dis Sci 1996; 41:578584. MEDLINE
  • 23
    Lind CD, Malisch TW, Chong WK, Richards WO, Pinson CW, Meranze SG, Mazer M. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology 1994; 106:12771283. MEDLINE
  • 24
    LaBerge JM, Somberg KA, Lake JR, Gordon RL, Kerlan RK, Ascher NL, Roberts JP, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995; 108:11431151. MEDLINE
  • 25
    Sanyal AJ, Freedman AM, Luketic VA, Purdum PP III, Shiffman ML, DeMeo J, Cole PE, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112:889898. MEDLINE
  • 26
    Groszmann RJ, Bendtsen F, Bosch J, Fleig W, Grace N, Lebrec D, Merkel C, Vinel JP. Baveno II consensus statements: drug therapy for portal hypertension. In: De FranchisR, ed. Portal Hypertension II: Proceedings of the Second Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies, Oxford: Blackwell Science 1996: 9899.
  • 27
    Grace ND, Groszmann RJ, García-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, Bosch J, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998; 28:868880. MEDLINE
  • 28
    D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999; 19:475506. MEDLINE
  • 29
    Villanueva C, Balanzó J, Novella M, Soriano G, Sáinz S, Torras X, Cussó X, et al. Nadolol plus isosorbide-5-mononitrate compared with sclerotherapy for the prevention of variceal bleeding. N Engl J Med 1996; 334:16241629. MEDLINE
  • 30
    Gallego A, Villanueva C, Ortiz J, Miñana J, Soriano G, Ricart E, Torras X, et al. A randomized trial comparing endoscopic ligation with nadolol plus isosorbide-5-mononitrate for the prevention of variceal rebleeding. Preliminary results. J Hepatol 1998; 28(suppl 1):74.
  • 31
    Goulis J, Patch D, Greenslade L, Gerunda G, Merkel C, Burroughs AK. RCT of variceal ligation vs propranolol-isosorbide for variceal rebleeding with target pressure reduction: Methodological problems. J Hepatol 1998; 28(suppl 1):74.
  • 32
    Karnofski DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents against cancer. In: Mc LoedCM, ed. Evaluations of Chemotherapeutic Agents. New York: Columbia University Press, 1949.
  • 33
    Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and HQL. Medical Care 1989; 27:217S232S.
  • 34
    Hunt SM, McEwen J, McKenna SP. Measure Health Status. London: Croom Helm, 1986.
  • 35
    Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, Loguercio C, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001; 120:170178. MEDLINE
  • 36
    D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22:332354. MEDLINE
  • 37
    Provenzale D. Economic considerations for the hepatologist. Hepatology 1999; 29(Suppl 1):13S17S. MEDLINE
  • 38
    Feu F, García-Pagán JC, Bosch J, Luca A, Terés J, Escorsell A, Rodés J. Relation between portal pressure response to pharmacological therapy and risk of recurrent variceal hemorrhage in patients with cirrhosis. Lancet 1995; 346:10561059. MEDLINE
  • 39
    Groszmann RJ, Bosch J, Grace ND, Conn HO, García-Tsao G, Navasa M, Fischer R, et al. Hemodynamic events in a prospective randomized trial of propranolol vs placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990; 99:14011407. MEDLINE
  • 40
    Vorobioff J, Groszmann RJ, Picabea E, Gamen M, Villavicencio R, Bordato J, Morel I, et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology 1996; 111:701709. MEDLINE